IL92464A - Quinoxaline compounds their preparation and pharmaceutical compositions containing them - Google Patents

Quinoxaline compounds their preparation and pharmaceutical compositions containing them

Info

Publication number
IL92464A
IL92464A IL9246489A IL9246489A IL92464A IL 92464 A IL92464 A IL 92464A IL 9246489 A IL9246489 A IL 9246489A IL 9246489 A IL9246489 A IL 9246489A IL 92464 A IL92464 A IL 92464A
Authority
IL
Israel
Prior art keywords
compound
quinoxaline
dione
mmol
hydroxy
Prior art date
Application number
IL9246489A
Other languages
English (en)
Other versions
IL92464A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL92464A0 publication Critical patent/IL92464A0/xx
Publication of IL92464A publication Critical patent/IL92464A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Television Signal Processing For Recording (AREA)
  • Luminescent Compositions (AREA)
IL9246489A 1988-12-22 1989-11-27 Quinoxaline compounds their preparation and pharmaceutical compositions containing them IL92464A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK716188A DK716188D0 (da) 1988-12-22 1988-12-22 Quinoxalinforbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
IL92464A0 IL92464A0 (en) 1990-08-31
IL92464A true IL92464A (en) 1995-07-31

Family

ID=8149233

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9246489A IL92464A (en) 1988-12-22 1989-11-27 Quinoxaline compounds their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5081123A (fr)
EP (1) EP0374534B1 (fr)
JP (1) JPH02221264A (fr)
AT (1) ATE108182T1 (fr)
AU (1) AU624885B2 (fr)
CA (1) CA2004077A1 (fr)
DE (1) DE68916626T2 (fr)
DK (1) DK716188D0 (fr)
ES (1) ES2057076T3 (fr)
FI (1) FI896236A0 (fr)
IE (1) IE65171B1 (fr)
IL (1) IL92464A (fr)
NO (1) NO178662C (fr)
NZ (1) NZ231905A (fr)
PT (1) PT92717B (fr)
ZA (1) ZA899470B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308845A (en) * 1988-12-22 1994-05-03 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
EP0647137B1 (fr) * 1992-06-22 2008-08-13 The Regents Of The University Of California Antagonistes des recepteurs de glycine et leur utilisation
AU680632B2 (en) * 1992-10-13 1997-08-07 Neurosearch A/S Quinoxalinedione derivatives as EAA antagonists
DK12293D0 (da) * 1993-02-02 1993-02-02 Novo Nordisk As Heterocykliske forbindelser og deres fremstilling og anvendelse
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
US5500420A (en) * 1993-12-20 1996-03-19 Cornell Research Foundation, Inc. Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
JPH09510695A (ja) * 1994-01-03 1997-10-28 エイシア・ファーマシュウティカルズ，インコーポレイテッド ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
EP0705834A1 (fr) * 1994-07-27 1996-04-10 Ciba-Geigy Ag Quinoxaline-2,3-diones à anneau fusionné azahétérocyclique
EP0705835A1 (fr) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Quinoxaline-2,3-diones à anneau fusionné oxa- ou thiahétérocyclique
EP0783506A1 (fr) * 1994-09-30 1997-07-16 Basf Aktiengesellschaft Nouvelles imidazoloquinoxalinones heterocycliques substituees, leur preparation et leur utilisation
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
US5721234A (en) * 1994-12-07 1998-02-24 Warner-Lambert Company Glutamate receptor antagonists: fused cycloalkylouinoxalinediones
AU4423496A (en) 1995-03-14 1996-10-02 Warner-Lambert Company Novel glutamate (ampa/kainate) receptor antagonists: n-substituted fused azacycloalkylquinoxalinediones
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
US5968928A (en) * 1996-09-19 1999-10-19 Warner-Lambert Company Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof
CA2540638A1 (fr) * 2003-09-30 2005-04-14 Janssen Pharmaceutica N.V. Composes de quinoxaline
KR101292707B1 (ko) * 2004-02-23 2013-08-02 트러스티즈 오브 터프츠 칼리지 디펩티딜펩티다아제 ⅳ의 억제제
CN1942182B (zh) * 2004-02-23 2010-05-26 塔夫茨大学信托人 调节葡萄糖代谢的二肽基肽酶ⅳ抑制剂
AU2011203039B2 (en) * 2004-02-23 2013-02-21 Trustees Of Tufts College Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
EP2338492A1 (fr) 2009-12-24 2011-06-29 Universidad del Pais Vasco Procédés et compositions pour le traitement de la maladie d'Alzheimer
EP3427729A1 (fr) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar

Also Published As

Publication number Publication date
AU4687489A (en) 1990-06-28
NO178662B (no) 1996-01-29
DE68916626T2 (de) 1994-10-27
CA2004077A1 (fr) 1990-06-22
NO895196D0 (no) 1989-12-21
EP0374534A1 (fr) 1990-06-27
US5081123A (en) 1992-01-14
PT92717A (pt) 1990-06-29
EP0374534B1 (fr) 1994-07-06
JPH02221264A (ja) 1990-09-04
AU624885B2 (en) 1992-06-25
ES2057076T3 (es) 1994-10-16
DE68916626D1 (de) 1994-08-11
DK716188D0 (da) 1988-12-22
IE893750L (en) 1990-06-22
ATE108182T1 (de) 1994-07-15
ZA899470B (en) 1990-09-26
NO895196L (no) 1990-06-25
FI896236A0 (fi) 1989-12-22
NO178662C (no) 1996-05-08
NZ231905A (en) 1991-11-26
IL92464A0 (en) 1990-08-31
IE65171B1 (en) 1995-10-04
PT92717B (pt) 1995-12-29

Similar Documents

Publication Publication Date Title
US5081123A (en) Quinoxaline compound and their preparation and use
US4948794A (en) Cycloalkyl or benzyl-6-substituted-quinoxalinediones
US5061706A (en) 2,3-quinoxalinediones for use as neuroleptics
US5079250A (en) Tricyclic heterocyclic diols and their preparation and use
US4912108A (en) Pyridoquinoxaline compounds and their preparation and use as glutamate antagonists
IL97405A (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
US4812458A (en) 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
IE66149B1 (en) Quinoxaline compounds and their preparation and use
US5308845A (en) Quinoxaline compounds and their preparation and use
IL97913A (en) (1)Benzothieno (2,3-b) pyrazine-2, 3 (1h,4h)-diones, their preparation and pharmaceutical compositions containing them
US5153195A (en) Quinoxaline compounds and their preparation and use
DK165293B (da) Quinoxalinforbindelser, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater indeholdende forbindelserne
DK165294B (da) Quinoxalinforbindelser, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater indeholdende forbindelserne

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void